Bookmarks (4) clear filters

Summary List PlacementGood news about coronavirus vaccines keeps rolling in. On Friday, Pfizer's coronavirus vaccine became the first candidate to receive emergency authorization in the US. The day before, an advisory committee to the Food and Drug Administration recommended the shot for widespread use in peoples ages 16 and older. Moderna's shot could be next: The company applied for an emergency use authorization (EUA)...

Summary List PlacementEvan Fein can't know for sure, but he is pretty certain he got Pfizer's experimental coronavirus vaccine about five months ago.  "I think I got a real vaccine, and not a placebo," Fein said, during a public comment period the Food and Drug Administration held on Thursday afternoon. The comment period was part of an advisory committee hearing, where top disease experts...

Summary List Placement The US Food and Drug Administration will be hosting a meeting in just under three weeks to consider an emergency use authorization for Pfizer's COVID-19 vaccine, the agency announced Friday. Earlier this week, the pharmaceutical giant revealed that its experimental vaccine is 95% effective at preventing transmission of the coronavirus, citing a clinical trial involving more than 43,000 people. Only mild...

Summary List Placement The US clinical trial of AstraZeneca's COVID-19 vaccine will be suspended for the next several days as the US Food and Drug Administration investigates a potential side effect, according to Reuters. Sources told the news agency on Monday that enrollment in the trial was not being reopened "until at least midweek," pending the investigation. The FDA did not immediately respond to...